Kasvu Therapeutics
PrivateLast Round
Series A
Sep 24, 2026
Total Funding Raised
$34M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Kasvu Therapeutics is a biotechnology company that develops non-hallucinogenic small molecule neuroplastogens for the treatment of neuropsychiatric and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kasvu Therapeutics Comparables
Compare Kasvu Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delix Therapeutics | 85% | |
| Connecta Therapeutics | 84% | |
| Five Discovery | 84% |
Kasvu Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 24, 2026 | ||||
| Seed | Sep 1, 2024 |
Kasvu Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordic Science Investments | Seed, Series A |
| Tesi | Series A |
| Innovestor | Seed, Series A, Pre Seed |
| Helsinki University Funds | Series A |
| Hadean Ventures | Series A |
| Stephen Industries Inc Oy | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
$34M round led by Hadean Ventures.
- Aug 22, 2026
Monthly visitors grew 616% MoM, reaching 3.9K.
Recent news
Latest coverage and updates
- receives_financingSep 24, 2026
Kasvutx receives $34.2M in Series A financing led by Hadean Ventures, with participation from Tesi, Innovestor Life Science Fund, and other investors, in Finland on Sep 24th '26 to advance KTX-0141 through IND/CTA-enabling studies and Phase 1/1b development for major depressive disorder.
Kasvu Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kasvu Therapeutics's valuation, stock price, and market status.
Is Kasvu Therapeutics a public or private company?
Kasvu Therapeutics is a private company.
What is the current stock price of Kasvu Therapeutics?
Kasvu Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kasvu Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kasvu Therapeutics worth (valuation)?
Valuation information for Kasvu Therapeutics is not publicly available.
Can I buy Kasvu Therapeutics stock?
Kasvu Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kasvu Therapeutics's last funding round?
Kasvu Therapeutics's most recent funding round was Series A on September 24, 2026.
Who are the main investors in Kasvu Therapeutics?
Key investors in Kasvu Therapeutics include Innovestor, Hadean Ventures.
Will Kasvu Therapeutics IPO soon?
No public IPO plans have been announced for Kasvu Therapeutics.
How can I track Kasvu Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kasvu Therapeutics's shares on secondary markets.